VIA
STJ

Vantage Investment Advisors’s St Jude Medical STJ Stock Holding History

Vantage Investment Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,098
Closed -$88K – 842
2016
Q4 		$88K Hold
1,098
– – 0.04% 181
2016
Q3 		$88K Buy
+1,098
New +$88.6K 0.04% 178

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Vantage Investment Advisors's STJ Position: Q1 2017 in Review

Vantage Investment Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,098 shares — an estimated $88K sold.

Vantage Investment Advisors first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $88K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Vantage Investment Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Vantage Investment Advisors sold 1,098 St Jude Medical shares in Q1 2017, an estimated $88K.
  • Vantage Investment Advisors first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • Vantage Investment Advisors's St Jude Medical position peaked at $88K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Vantage Investment Advisors's 13F filing for Q1 2017, filed 12 May 2017.